NCT06025032View on ClinicalTrials.gov

a Study in Subjects With Otoferlin Mutation-related Hearing Loss Using RNA Base-eDiting Therapy(SOUND)

EARLY_PHASE1WithdrawnINTERVENTIONAL
0
Timeline

Start Date

March 30, 2023

Primary Completion Date

April 8, 2025

Study Completion Date

April 8, 2025

Conditions
Congenital Hearing Loss
Interventions
GENETIC

HG205

The study will enroll up to 2 cohorts, evaluating a starting dose plus a higher or lower dose

Trial Locations (1)

Unknown

Eye & ENT Hospital of Fudan University, Shanghai

Sponsors
All Listed Sponsors
collaborator

Eye & ENT Hospital of Fudan University

OTHER

lead

HuidaGene Therapeutics Co., Ltd.

INDUSTRY